Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What Healthcare's Rotation Means for Polar Capital Global Healthcare Trust in the FTSE 250 (LSE:PCGH)

Polar Capital Global Healthcare Trust (LSE:PCGH), the FTSE 250-listed specialistInvestmenttrust focused on healthcare companies worldwide, enters the closing months of its financial year against an unusually complex backdrop for its sector. Healthcare has lagged the broader stock market for much of the period since …

Ankur Sharma | 07 October 2026

How Oxford Nanopore Is Trying to Win Back FTSE 250 Investors After a Bruising Year (LSE:ONT)

Oxford Nanopore Technologies (LSE:ONT) has spent much of 2026 trying to rebuild credibility with investors. The FTSE 250 gene sequencing specialist reported half-year results showing revenue of £116.7 million for the six months to 30 June, up 11%, or 12% at constant currency. Losses …

Ankur Sharma | 07 October 2026

Why Is Avacta (LSE:AVCT) Raising £12.5m for Its Oncology Development Programme?

• New shares were issued through a placing and subscription at 68p.

Ankur Sharma | 07 October 2026

Why Genus Is Returning Cash to Shareholders After a Transformative Year in the FTSE 250 (LSE:GNS)

Genus (LSE:GNS), the porcine and bovine genetics specialist, has spent the past month putting its strengthenedBalance Sheetto work. Preliminary results for the year to 30 June 2026, published on 10 September, were accompanied by the launch of a £60m share buyback programme for the …

Ankur Sharma | 07 October 2026

What Hikma's New CFO Appointment Means for the FTSE 250 Drugmaker's Turnaround (LSE:HIK)

Hikma Pharmaceuticals (LSE:HIK) has filled one of the most closely watched gaps in its senior team. On 24 September the generic and branded medicines group announced that Rebecca Hall will join as chief financial officer and an executive director in the first quarter of …

Ankur Sharma | 07 October 2026

Could Faron Pharmaceuticals’ (LSE:FARN) Shareholder Changes Add a New Catalyst to Its Biotech Story?

• Faron has updated the composition of its shareholders’ nomination board.

Ankur Sharma | 07 October 2026

Could Advanced Medical Solutions’ (AIM:AMS) Acquisition Financing Mark the Final Stage of Its Takeover?

• Financing materials have been published in connection with the recommended cashAcquisitionof Advanced Medical Solutions.

Ankur Sharma | 07 October 2026

Oxford Nanopore Technologies (LSE:ONT) Shares Jump 4.91% to Fresh 52-Week High as Patent Win and Upgrades Fuel Rally

The momentum has been striking. Over a two-week period, the shares moved from about 173p to 182p, then jumped to 199.4p and 217.6p in successive sessions at the end of September, touching an intraday high of 218.4p before consolidating near 214p. The latest gain …

Ankur Sharma | 07 October 2026

Why Is Cambridge Cognition (LSE:COG) Joining a Major NHS Alzheimer’s Study?

• The 15-month study aims to recruit 500 participants with memory complaints or early cognitive-decline symptoms.

Ankur Sharma | 07 October 2026

Why Is Poolbeg Pharma (LSE:POLB) Strengthening Its POLB001 Patent Position in South Korea?

• The patent covers prevention of cancer immunotherapy-associated cytokine release syndrome.

Ankur Sharma | 07 October 2026
Support

Hi! How can we help you today?

Loading…